TOTVS S.A. (TTVSY)

ASLAN Pharmaceuticals Revenue

TOTVS had revenue of 1.49B BRL in the quarter ending June 30, 2025, with 16.96% growth. This brings the company's revenue in the last twelve months to 5.68B, up 17.93% year-over-year. In the year 2024, TOTVS had annual revenue of 5.22B with 17.65% growth.

• Revenue (ttm): 5.68B BRL
• Revenue Growth: +17.93%
• P/S Ratio: 4.43
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.62B USD

Revenue Chart

* This company reports financials in BRL.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.22B	783.56M	17.65%
Dec 31, 2023	4.44B	647.51M	17.07%
Dec 31, 2022	3.79B	815.62M	27.39%
Dec 31, 2021	2.98B	381.24M	14.69%
Dec 31, 2020	2.60B	313.95M	13.76%